Védrines, Philippe, M.D.
Quick facts
Marketed products
- addition of azathioprine · Immunology
Azathioprine is a purine analog that inhibits T-cell and B-cell proliferation by interfering with nucleotide synthesis, thereby suppressing immune responses. - Switch to a second anti-TNF drug alone · Immunology / Rheumatology
Switching to a second anti-TNF agent involves discontinuing one TNF inhibitor and initiating a different TNF inhibitor to maintain or restore therapeutic response in inflammatory conditions.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Védrines, Philippe, M.D.
What are Védrines, Philippe, M.D.'s marketed drugs?
Top marketed products include addition of azathioprine, Switch to a second anti-TNF drug alone.
Related
- addition of azathioprine · Immunology
- Switch to a second anti-TNF drug alone · Immunology / Rheumatology
- Sector hub: All tracked pharma companies